Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Current Assets (2018 - 2021)

Historic Current Assets for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $241.5 million.

  • Black Diamond Therapeutics' Current Assets fell 2820.28% to $241.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $241.5 million, marking a year-over-year decrease of 2820.28%. This contributed to the annual value of $319.6 million for FY2020, which is 10521.85% up from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Current Assets of $241.5 million as of Q3 2021, which was down 2820.28% from $270.9 million recorded in Q2 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Current Assets peaked at $362.1 million during Q1 2020, and registered a low of $51.7 million during Q4 2018.
  • In the last 4 years, Black Diamond Therapeutics' Current Assets had a median value of $270.9 million in 2021 and averaged $249.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 20128.09% in 2019, then plummeted by 2820.28% in 2021.
  • Black Diamond Therapeutics' Current Assets (Quarter) stood at $51.7 million in 2018, then surged by 201.28% to $155.7 million in 2019, then surged by 105.22% to $319.6 million in 2020, then decreased by 24.41% to $241.5 million in 2021.
  • Its Current Assets was $241.5 million in Q3 2021, compared to $270.9 million in Q2 2021 and $297.3 million in Q1 2021.